ABELZETA
LIVE

Serial Number

98350102

Owner

ABELZETA INC.

Attorney

Lauren Beth Emerson

Filing Date

Jan 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ABELZETA Trademark

Serial Number: 98350102

ABELZETA is a trademark filed by ABELZETA INC. on January 10, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ABELZETA INC. (6 trademarks)

9605 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE, MD 20850

Entity Type: 03

Trademark Details

Filing Date

January 10, 2024

Registration Date

Not Registered

Published for Opposition

November 12, 2024

Goods & Services

Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; biological preparations, namely, viral vectors and plasmids for medical use for the treatment of cancer and autoimmune diseases; cells for medical use

Research and development of new products for others; scientific research; gene therapy research; research in the field of cell engineering technology; stem cell research services; scientific research in the field of genetics; biomedical research services; medical research; biological research; providing medical and scientific research information in the field of clinical trials; culturing of cells for others for scientific research purposes

Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use

Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services; medical diagnostic services

Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; biological preparations, namely, viral vectors and plasmids for research

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 12, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 10, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2025 EXRA
CORRECTED NOA E-MAILED
Nov 25, 2025 NOAC
SOU EXTENSION 1 GRANTED
Nov 25, 2025 EX1G
DIVISIONAL PROCESSING COMPLETE
Nov 25, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 24, 2025 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 23, 2025 REAP
DIVISIONAL REQUEST RECEIVED
Jun 3, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 3, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
Jun 3, 2025 EEXT
SOU EXTENSION 1 FILED
Jun 2, 2025 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 20, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 29, 2024 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2024 NWOS
NEW APPLICATION ENTERED
Jan 10, 2024 NWAP